New cancer drug AGX101 enters human trials for advanced tumors
Disease control
Recruiting now
This early-stage trial tests AGX101, a drug that delivers chemotherapy directly to cancer cells by targeting a protein called TM4SF1. About 80 adults with advanced solid tumors (like breast, prostate, or pancreatic cancer) who have run out of standard options will receive the dru…
Phase: PHASE1 • Sponsor: Angiex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC